Investor Overview ‹ Arena Pharmaceuticals, Inc.

Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs for weight management, cardiovascular disease, inflammation and other disorders.

Our internally discovered and developed drug, BELVIQ^® (lorcaserin HCl) is approved by the US Food and Drug Administration. Following are links to certain additional information:

We have granted exclusive marketing and distribution rights to Eisai Inc. for most of North and South America, and to Ildong Pharmaceutical Co., Ltd., for South Korea. We plan to enter into additional collaborations to commercialize BELVIQ outside of these territories.

Stock Information

Ticker:

ARNA

Exchange:

NASDAQ

Price:

7.12

Change:

+ 0.04

Open:

7.10

Previous Close: